Morningstar Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $608K | Buy |
+1,159
| New | +$608K | 0.05% | 103 |
|
|
2025
Q1 | – | Sell |
-954
| Closed | -$680K | – | 189 |
|
|
2024
Q4 | $680K | Hold |
954
| – | – | 0.05% | 103 |
|
|
2024
Q3 | $968K | Buy |
954
+248
| +35% | +$252K | 0.1% | 93 |
|
|
2024
Q2 | $742K | Hold |
706
| – | – | 0.08% | 102 |
|
|
2024
Q1 | $680K | Hold |
706
| – | – | 0.07% | 111 |
|
|
2023
Q4 | $620K | Sell |
706
-2
| -0.3% | -$1.76K | 0.07% | 114 |
|
|
2023
Q3 | $583K | Hold |
708
| – | – | 0.08% | 89 |
|
|
2023
Q2 | $509K | Buy |
+708
| New | +$509K | 0.07% | 101 |
|